To assess the therapeutic effects of ILA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice, rotarod, cylinder, and OF tests were performed (Fig. 1C). Here, TNFRSF9 is linked to Parkinson disease.